Cepharanthine, a regulator of keap1-Nrf2, inhibits gastric cancer growth through oxidative stress and energy metabolism pathway.
Cepharanthine (CEP) derived from Stephania Cephalantha Hayata inhibits gastric cancer cell growth by inducing apoptosis and cell cycle arrest. It also regulates oxidative stress and alters energy metabolism, suggesting potential for gastric cancer treatment.
- Lu YY et al (2023).
- Cell Death Discov.
- PubMed:
- 38086844